RSS feeds in the directory: 374
Added today: 0
Added yesterday: 0
The Company AFK "System" together with VTB Bank acquired a package of shares of JSC "Pharmaceutical company "Obolensky" (OBL Pharm) the company Alvansa Ltd, the main shareholders of which are Gazprombank and UFG Private Equity. The message about the deal posted on the website of Sistema JSFC.
the Consortium, which in addition to the VTB and "Systems" includes the management of the OP "Obolenskoe" has acquired a 95,14% stake in a pharmaceutical plant for 15.5 billion rubles, the Effective share of AFK Sistema in OBL Pharm said the deal amounted to 11.7%, says the company.
"Partners are investing through a joint holding company Ristango Holding Limited, which signed a shareholders' agreement providing for the rights of all investors to participate in management. Between Sistema and VTB also signed an agreement to acquire shares of VTB in Ristango Holding Limited no later than three years from the date of the transaction", — stated in the message.
in addition, the transaction at the beginning of 2019 can join the Russian direct investment Fund (RDIF), said the company. This will be possible "after further consideration and negotiation of the terms of such transaction from the RDIF led the consortium of investors".
"the Experience and financial resources of the VTB group will significantly enhance shareholder value and provide attractive returns as current shareholders and potential new investors," — are reported words of the first Deputy President — Chairman of Board VTB Yuri Soloviev.
Why "System" buys a plant
the Deal should help "the System", the asset which has a pharmaceutical plant Binnopharm to create a "leading pharmaceutical holding company in Russia" is able to enter the top 10 commercial companies in the pharmaceutical industry.
the Production capacity of the combined company, which will be completed in the first half of 2019 — four pharmaceutical plants in Moscow and the Moscow region.
the company will be able to produce about 200 drugs with the "flagships" in the form of venotonic "Benarus", probiotic "Maxilac" and hepaprotective "Endoxa".
that AFK "System" and the Russian-Chinese investment Fund (RCIF established by the RDIF and China investment Corporation in 2012) plan to invest in the Pharma business, RBC wrote in early October.
the Plans to acquire JSC "Pharmaceutical company "Obolensky" the interlocutors RBC was then described as "negotiations are at an advanced stage". According to sources, the initiator of the negotiation and the search farmaktivy made it "the System", whose strategy is expansion of farmapine.
Reuters: Ruble stabilized after the oil is at the pre-auction 28.12.2018 at 08:00
Rossiyskaya Gazeta: Experts have called the most demanded profession 2019 28.12.2018 at 07:50
Kommersant: Leasing of ships moving out in the future 19.12.2018 at 20:01
Gazeta.Ru From gasoline to wine: what will rise in 2019 19.12.2018 at 10:30
RBC: Business to discuss with the authorities the development of "law on laws" 19.12.2018 at 08:30
Reuters: Ruble rises to everywhere falling before the fed the dollar 19.12.2018 at 08:00
RBC: Payment system "World" has developed a similar Google Pay 19.12.2018 at 07:50